<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04718922</url>
  </required_header>
  <id_info>
    <org_study_id>20110961173</org_study_id>
    <nct_id>NCT04718922</nct_id>
  </id_info>
  <brief_title>Chlorhexidine Mouthrinse Before EBUS-TBNA</brief_title>
  <acronym>CHX_EBUS</acronym>
  <official_title>Effect of Chlorhexidine Mouthrinse on Prevention of Microbial Contamination During EBUS-TBNA: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether chlorhexidine mouthrinse is effective in&#xD;
      preventing microbial contamination during endobronchial ultrasound-guided transbronchial&#xD;
      needle aspiration (EBUS-TBNA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EBUS-TBNA using the convex probe is a standard of care for the assessment of mediastinal and&#xD;
      hilar lymphadenopathy. Although EBUS-TBNA is a minimally invasive procedure, rare but serious&#xD;
      infectious complications such as pneumonia, lung abscess, empyema, mediastinal&#xD;
      adenitis/abscess, mediastinitis, pericarditis, and sepsis were reported. EBUS-scope might be&#xD;
      contaminated with oropharyngeal commensal bacteria while passing the oropharyngeal airway&#xD;
      during EBUS-TBNA. Contamination of punctured lymph nodes by oropharyngeal commensal bacteria&#xD;
      can cause severe infections.&#xD;
&#xD;
      Chlorhexidine gluconate is an antimicrobial agent that has a broad antibacterial activity&#xD;
      including both gram-positive and negative bacteria. Chlorhexidine has been widely used for&#xD;
      surgical scrub, skin disinfection, and mouthrinse. We, therefore, designed a phase 4,&#xD;
      single-center, randomized, controlled clinical trial to investigate whether chlorhexidine&#xD;
      mouthrinse is effective in preventing microbial contamination during EBUS-TBNA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 20, 2021</start_date>
  <completion_date type="Anticipated">December 11, 2021</completion_date>
  <primary_completion_date type="Actual">June 11, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colony forming unit (CFU) counts of EBUS-TBNA needle wash solution in aerobic media</measure>
    <time_frame>Needle wash solution is obtained immediately after termination of EBUS-TBNA</time_frame>
    <description>Needle wash solution is obtained by instilling 5mL of sterile physiological saline into the puncture needle.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CFU counts of EBUS-TBNA needle wash solution in anaerobic media</measure>
    <time_frame>Needle wash solution is obtained immediately after termination of EBUS-TBNA</time_frame>
    <description>Needle wash solution is obtained by instilling 5mL of sterile physiological saline into the puncture needle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fever</measure>
    <time_frame>24 hours after EBUS-TBNA</time_frame>
    <description>Fever is defined as a temperature ≥37.8°C.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>4 weeks after EBUS-TBNA</time_frame>
    <description>Infectious complications include pneumonia, lung abscess, empyema, mediastinal adenitis/abscess, mediastinitis, pericarditis, and sepsis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Endobronchial Ultrasound</condition>
  <arm_group>
    <arm_group_label>Experimental Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mouthrinse with 100 ml 0.12% chlorhexidine for 1 min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No mouthrinse</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine Gluconate 0.12 % Mouthwash</intervention_name>
    <description>Intervention with chlorhexidine mouthrinse will be performed approximately 10 min before the start of EBUS-TBNA</description>
    <arm_group_label>Experimental Arm</arm_group_label>
    <other_name>Hexamedine Sol.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  inpatients aged 19 years and older who are scheduled to undergo EBUS-TBNA using a&#xD;
             convex probe&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  antiseptic mouthrinse within 7 days before inclusion;&#xD;
&#xD;
          -  active infection or antibiotic treatment within 7 days before inclusion;&#xD;
&#xD;
          -  immunocompromised;&#xD;
&#xD;
          -  trachemostomy status;&#xD;
&#xD;
          -  who have already undergone gastroscopy on the same day when EBUS- TBNA is scheduled to&#xD;
             be administered&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaeyoung Cho, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 20, 2021</study_first_submitted>
  <study_first_submitted_qc>January 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jaeyoung Cho</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Endobronchial ultrasound</keyword>
  <keyword>Transbronchial needle aspiration</keyword>
  <keyword>Chlorhexidine</keyword>
  <keyword>Infection</keyword>
  <keyword>Complication</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

